114 related articles for article (PubMed ID: 38226993)
21. GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma.
Zhai JP; Liu ZH; Wang HD; Huang GL; Man LB
Oncol Lett; 2022 Jan; 23(1):36. PubMed ID: 34966452
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategy.
Han R; Yu L; Zhao C; Li Y; Ma Y; Zhai Y; Qian Z; Gu Y; Li S
Biomaterials; 2022 Sep; 288():121723. PubMed ID: 35963816
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model.
Schiffer S; Hansen HP; Hehmann-Titt G; Huhn M; Fischer R; Barth S; Thepen T
Blood Cancer J; 2013 Mar; 3(3):e106. PubMed ID: 23524591
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of the new GRPR-antagonist
Lymperis E; Kaloudi A; Kanellopoulos P; Krenning EP; de Jong M; Maina T; Nock BA
J Labelled Comp Radiopharm; 2019 Aug; 62(10):646-655. PubMed ID: 30963606
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of transforming growth factor-β release from tumor cells reduces their motility associated with epithelial-mesenchymal transition.
Ohshio Y; Teramoto K; Hashimoto M; Kitamura S; Hanaoka J; Kontani K
Oncol Rep; 2013 Aug; 30(2):1000-6. PubMed ID: 23715805
[TBL] [Abstract][Full Text] [Related]
26. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
27. Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1.
Sun C; Nagaoka K; Kobayashi Y; Nakagawa H; Kakimi K; Nakajima J
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771674
[TBL] [Abstract][Full Text] [Related]
28. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
29. Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management.
D'Oronzo S; Coleman R; Brown J; Silvestris F
J Bone Oncol; 2019 Apr; 15():004-4. PubMed ID: 30937279
[TBL] [Abstract][Full Text] [Related]
30. Incidence and consequences of bone metastases in lung cancer patients.
Kuchuk M; Addison CL; Clemons M; Kuchuk I; Wheatley-Price P
J Bone Oncol; 2013 Feb; 2(1):22-9. PubMed ID: 26909268
[TBL] [Abstract][Full Text] [Related]
31. Gene and miRNA expression signature of Lewis lung carcinoma LLC1 cells in extracellular matrix enriched microenvironment.
Stankevicius V; Vasauskas G; Bulotiene D; Butkyte S; Jarmalaite S; Rotomskis R; Suziedelis K
BMC Cancer; 2016 Oct; 16(1):789. PubMed ID: 27729023
[TBL] [Abstract][Full Text] [Related]
32. Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases.
Steindl A; Yadavalli S; Gruber KA; Seiwald M; Gatterbauer B; Dieckmann K; Frischer JM; Klikovits T; Zöchbauer-Müller S; Grisold A; Hoda MAR; Marosi C; Widhalm G; Preusser M; Berghoff AS
Cancer; 2020 Oct; 126(19):4341-4352. PubMed ID: 32678971
[TBL] [Abstract][Full Text] [Related]
33. Targeting c-Jun Is a Potential Therapy for Luminal Breast Cancer Bone Metastasis.
Han Y; Katayama S; Futakuchi M; Nakamichi K; Wakabayashi Y; Sakamoto M; Nakayama J; Semba K
Mol Cancer Res; 2023 Sep; 21(9):908-921. PubMed ID: 37310848
[TBL] [Abstract][Full Text] [Related]
34. Targeted sequencing reveals distinct pathogenic variants in Chinese patients with lung adenocarcinoma brain metastases.
Ma Y; Chen K; Yang Z; Guan M
Oncol Lett; 2018 Apr; 15(4):4503-4510. PubMed ID: 29541220
[TBL] [Abstract][Full Text] [Related]
35. Exosomal hsa-miR-151a-3p and hsa-miR-877-5p are potential novel biomarkers for predicting bone metastasis in lung cancer.
Zhao K; Jia C; Wang J; Shi W; Wang X; Song Y; Peng C
Aging (Albany NY); 2023 Dec; 15(24):14864-14888. PubMed ID: 38180107
[TBL] [Abstract][Full Text] [Related]
36. Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis.
Li S; Qu Y; Liu L; Zhang X; He Y; Wang C; Guo Y; Yuan L; Ma Z; Bai H; Wang J
Cell Biosci; 2023 Sep; 13(1):180. PubMed ID: 37770976
[TBL] [Abstract][Full Text] [Related]
37. Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model.
Takeda M; Sakamoto H; Shibasaki N; Fukui T; Magaribuchi T; Sumiyoshi T; Utsunomiya N; Sawada A; Goto T; Kobayashi T; Ueda K; Yamasaki T; Ogawa O; Akamatsu S
Front Oncol; 2023; 13():1139049. PubMed ID: 37064121
[TBL] [Abstract][Full Text] [Related]
38. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
[TBL] [Abstract][Full Text] [Related]
39. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Contreras-Zárate MJ; Ormond DR; Gillen AE; Hanna C; Day NL; Serkova NJ; Jacobsen BM; Edgerton SM; Thor AD; Borges VF; Lillehei KO; Graner MW; Kabos P; Cittelly DM
Front Oncol; 2017; 7():252. PubMed ID: 29164052
[TBL] [Abstract][Full Text] [Related]
40. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
